Navigation Links
Stop-Smoking Therapies Have Benefits, Risks for Pregnant Women
Date:9/26/2007

They boost the quit rate but raise odds of premature birth, experts note

WEDNESDAY, Sept. 26 (HealthDay News) -- Pregnant smokers can get help quitting with the use of nicotine replacement gum, patches or lozenges, according to a new study.

But the benefits of these therapies must be weighed against concerns about early birth, the researchers add.

Writing in the American Journal of Preventive Medicine, the authors noted that an independent safety board suspended recruitment for the study due to health problems among women taking nicotine replacement therapy, namely premature delivery at about 36 weeks.

Still, continuing smoking brings its own risks.

"Every pregnant woman wants to quit smoking. Every woman knows it's bad for her baby," lead author Kathryn Pollak, associate professor at Duke University Medical Center, in Durham, N.C., said in a prepared statement.

The researchers worked with a group of 181 female smokers in their second trimester of pregnancy. The smokers received cognitive behavioral therapy, including in-person and telephone counseling sessions, to help them cope with quitting smoking. The option to use nicotine replacement therapy in the form of gum, patches or lozenges was available to 122 of the women.

The researchers analyzed the women's cotinine saliva levels to determine their smoking status. Cotinine is the main product of nicotine after it is broken down in the body.

Seven weeks after starting the nicotine replacement therapies, one out of four women had quit, compared with only 8 percent of those who received counseling alone. At 38 weeks of gestation, 18 percent of the women using nicotine replacement therapies remained smoke-free, compared to 7 percent of the women receiving counseling.

However, the differences between the groups disappeared three months after delivery, as many more of the women in the counseling group successfully quit smoki
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Alternative therapies popular with Parkinsons patients
3. Prolonged survival not assured by psychological therapies for cancer patients
4. First head-to-head trials of once weekly Fosamax and Actonel therapies
5. Preventive Therapies Found to be More Effective in Managing Migraines
6. Ayurvedic Therapies Cashing In On Medical Tourism
7. Immune-Boosting Therapies Of No Use In Preventing Miscarriage
8. A urine test for ease in prescription of drugs and therapies
9. Non Hormonal Therapies for Menopause Not Proved to be Effective
10. Need for More Talking Therapies for Treating Depression
11. Are Alternative Therapies A Reliable Alternative?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... PITTSBURGH, PA (PRWEB) November 27, 2014 ... suffer the embarrassing side effects of urinary incontinence," said ... to it and developed this specialized accessory to prevent ... developed the Incontinence to absorb urine leakage. This prevents ... wearer from potential embarrassment. The pad ensures that the ...
(Date:11/27/2014)... Randy Dotinga HealthDay Reporter , ... seem pre-wired to acquire a second language, new research suggests. ... will likely gain a brain boost, the small study finds. ... learning," said study co-author Ping Li, co-director of the Center ... it,s even more interesting, Li said, that "the brain networks ...
(Date:11/27/2014)... Dennis Thompson HealthDay Reporter ... vaccine appears to be safe and produces an immune system ... to early clinical trial results reported by the U.S. National ... clinical trial for the vaccine paves the way for field-testing ... Sierra Leone as early as January, said Dr. Anthony Fauci, ...
(Date:11/27/2014)... In order to enable people to adapt to ... easy way to avoid touching a toilet seat and/or lid ... prototype of the patent-pending Toilet Tamer, a device that enables ... lid in a more sanitary manner. It avoids direct contact ... it promotes good hygiene and peace of mind. The portable ...
(Date:11/27/2014)... 2014 Jeffrey Carlini has practiced ... Charlotte area providing audits, reviews, compilations, tax preparation, ... of varying size across numerous industries. Jeff has ... all of their accounting and tax needs. , ... ProAdvisor Program. When asking Mr. Carlini about his ...
Breaking Medicine News(10 mins):Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:Early Trial Promising for Ebola Vaccine 2Health News:Early Trial Promising for Ebola Vaccine 3Health News:Jeffrey Carlini becomes Intuit Proadvisor and receives QuickBooks certification 2
... the length of time spent using mobile telephones has ... (RF) radiations.// It has been proposed that a precautionary ... at present, there is no convincing scientific data to ... ,In view of the proximity between radio-frequency source ...
... and resultant facial scarring. A new study in the ... the American Society for Dermatologic Surgery//, reports that patients ... showed significant improvement of mild to severe acne scars ... as facial resurfacing, dermabrasion and chemical peels. ...
... elbow has been enjoying the spot light following ace cricketer ... However, the condition is not uncommon in the sports arena//. ... called in medical parlance, is an affliction where the outer ... a result of a specific strain, overuse or a direct ...
... blood pressure (BP) increase is one of the most ... most patients the condition, although urgent, is not an ... no guidelines on how to treat patients with acute ... cause of excessive hypertension and therefore antianxiety treatment may ...
... Researchers from Children’s Hospital of Boston have reconstructed ... The researchers used amniotic fluid for growing the ... these living tissues into lambs, while they were ... is used for altering birth defects. Undifferentiated stem ...
... yeast strains might have spawned an outbreak of disease ... British Columbia, Howard Hughes Medical Institute geneticists at Duke ... is normally restricted to the tropics and subtropics. ... in the pathogen's expansion may provide a useful model ...
Cached Medicine News:Health News:Mobile phones may influence normal brain functioning 2Health News:Tennis elbow not new among cricketers, say experts 2Health News:Anti-anxiety treatment found effective in lowering blood pressure 2Health News:Sex Played A Vital Role For Evolution Of Infectious Diseases 2
(Date:11/26/2014)... , November 25, 2014 ... Instruments Market by Power Source (Electric, Battery, Pneumatic), ... Cables, Blade, Burr, Cart), by Application (Orthopedic, ENT, ... published by MarketsandMarkets, the global Powered Surgical Instruments Market ... $1.6 Billion in 2014 and is expected to ...
(Date:11/26/2014)... , Nov. 25, 2014 Nanomix ... on the development of mobile diagnostic tests ... in hospital and pre-hospital settings, today announced ... 13485:2003 certification.  The certification was awarded by ... the world,s leading certification bodies. ...
(Date:11/26/2014)... OAKS, Calif. and LONDON , ... ) and AstraZeneca (NYSE: AZN ) today announced ... evaluating two doses of brodalumab in more than 1,800 patients ... with both Stelara ® (ustekinumab) and placebo at week ... brodalumab weight-based analysis group were each shown to be superior ...
Breaking Medicine Technology:Powered Surgical Instruments Market Worth $2.1 Billion by 2019 2Powered Surgical Instruments Market Worth $2.1 Billion by 2019 3Powered Surgical Instruments Market Worth $2.1 Billion by 2019 4Nanomix Receives ISO 13485:2003 Certification 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
... HypercleanTM 22 fume containment system ... a one- or two-person work ... containment system comes complete ... four charcoal filters. (For replacement ...
Surgical-grade stainless steel disposable concentric needle with Trocar tip has an insulated platinum-alloy core and two attached 61-cm (24-in) lead wires. Needles sold in packages of 20....
... Rotavirus is the most common ... for 5% of pediatric visits ... children under 5 years. ImmunoSTAT! ... to rule in or rule ...
... test delivers 100% specificity and 100% ... minutes. With as many as ... follow-up, this assay provides a test ... to detection and treatment while reducing ...
Medicine Products: